iRadimed
IRMD
91 hedge funds and large institutions have $187M invested in iRadimed in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 38 increasing their positions, 31 reducing their positions, and 21 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 31
1.21% more ownership
Funds ownership: 42.78% → 43.98% (+1.2%)
13% less funds holding
Funds holding: 104 → 91 (-13)
22% less capital invested
Capital invested by funds: $241M → $187M (-$53.5M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
52% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$6.84M |
| 2 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
+$3.1M |
| 3 |
BCM
Bares Capital Management
Austin,
Texas
|
+$2.42M |
| 4 |
Aviva
London,
United Kingdom
|
+$1.69M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCG
Resource Consulting Group
Orlando,
Florida
|
-$5.74M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
-$3.42M |
| 3 |
GIPM
G2 Investment Partners Management
New York
|
-$2.75M |
| 4 |
EGI
EAM Global Investors
Solana Beach,
California
|
-$1.92M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.5M |
IRMD Hedge Fund Activity: Q2 2022 in Review
91 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2022, worth a combined $187M — down 22% from $241M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of IRMD and 10 opened new positions — a net loss of 11 holders — while 31 trimmed existing stakes and 38 added.
The largest buyer was Soleus Capital Management, adding an estimated $6.84M. The largest seller was Resource Consulting Group, exiting entirely with an estimated $5.74M sold.
- 91 institutional investors held iRadimed (IRMD) as of Q2 2022, down from 104 in Q1 2022.
- Funds reported $187M of iRadimed stock for Q2 2022, down 22% quarter-over-quarter.
- 10 funds opened new iRadimed positions in Q2 2022 and 21 closed out, a net change of -11 holders.
- The largest iRadimed buyer in Q2 2022 was Soleus Capital Management, an estimated $6.84M added.
- The largest iRadimed seller in Q2 2022 was Resource Consulting Group, an estimated $5.74M sold.
Based on aggregated 13F filings for Q2 2022.